| e11 |
LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancerLAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
Haruko Kunitomi, Yusuke Kobayashi, Ren-Chin Wu, Takashi Takeda, Eiichiro Tominaga, Kouji Banno, Daisuke AokiHaruko Kunitomi, Yusuke Kobayashi, Ren-Chin Wu, Takashi Takeda, Eiichiro Tominaga, Kouji Banno, Daisuke Aoki
J Gynecol Oncol. 2020;31(2):e11. Published online 2019 August 21 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e11 |
|
| e12 |
Efficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: a meta-analysisEfficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: a meta-analysis
Xiaofeng Lv, Shihong Cui, Xiao'an Zhang, Chenchen RenXiaofeng Lv, Shihong Cui, Xiao'an Zhang, Chenchen Ren
J Gynecol Oncol. 2020;31(2):e12. Published online 2019 August 22 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e12 |
|
| e13 |
Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesionsPathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
Se Ik Kim, Se Jeong Kim, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom KimSe Ik Kim, Se Jeong Kim, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim
J Gynecol Oncol. 2020;31(2):e13. Published online 2019 August 22 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e13 |
|
| e14 |
Tozzi classification of diaphragmatic surgery in patients with stage IIIC–IV ovarian cancer based on surgical findings and complexityTozzi classification of diaphragmatic surgery in patients with stage IIIC–IV ovarian cancer based on surgical findings and complexity
Roberto Tozzi, Federico Ferrari, Joost Nieuwstad, Riccardo Garruto Campanile, Hooman Soleymani MajdRoberto Tozzi, Federico Ferrari, Joost Nieuwstad, Riccardo Garruto Campanile, Hooman Soleymani Majd
J Gynecol Oncol. 2020;31(2):e14. Published online 2019 September 2 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e14 |
|
| e15 |
Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort studyReal world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study
Soo Jin Park, Jihye Kim, Hee Seung Kim, Jeong-Won Lee, Ha Kyun Chang, Keun Ho Lee, Dae-Yeon Kim, Sunghoon Kim, Suk-Joon Chang, Seung Su Han, Sang-Yoon Park, Seung-Hyuk ShimSoo Jin Park, Jihye Kim, Hee Seung Kim, Jeong-Won Lee, Ha Kyun Chang, Keun Ho Lee, Dae-Yeon Kim, Sunghoon Kim, Suk-Joon Chang, Seung Su Han, Sang-Yoon Park, Seung-Hyuk Shim
J Gynecol Oncol. 2020;31(2):e15. Published online 2019 September 10 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e15 |
|
| e16 |
Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgeryCompletion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery
Jie Yang, Jiaxin Yang, Dongyan Cao, Keng Shen, Jiabin Ma, Fuquan ZhangJie Yang, Jiaxin Yang, Dongyan Cao, Keng Shen, Jiabin Ma, Fuquan Zhang
J Gynecol Oncol. 2020;31(2):e16. Published online 2019 September 17 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e16 |
|
| e19 |
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinomaSignificance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma
Moito Iijima, Noriyuki Okonogi, Nakako Izumi Nakajima, Yukie Morokoshi, Hiroaki Kanda, Taiju Yamada, Yusuke Kobayashi, Kouji Banno, Masaru Wakatsuki, Shigeru Yamada, Tadashi Kamada, Daisuke Aoki, Sumitaka HasegawaMoito Iijima, Noriyuki Okonogi, Nakako Izumi Nakajima, Yukie Morokoshi, Hiroaki Kanda, Taiju Yamada, Yusuke Kobayashi, Kouji Banno, Masaru Wakatsuki, Shigeru Yamada, Tadashi Kamada, Daisuke Aoki, Sumitaka Hasegawa
J Gynecol Oncol. 2020;31(2):e19. Published online 2019 September 26 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e19 |
|
| e20 |
Human papillomavirus (HPV) DNA detection in uterine cervix cancer after radiation indicating recurrence: a systematic review and meta-analysisHuman papillomavirus (HPV) DNA detection in uterine cervix cancer after radiation indicating recurrence: a systematic review and meta-analysis
Sasidharanpillai Sabeena, Santhosh Kuriakose, Binesh Damodaran, Nagaraja Ravishankar, Govindakarnavar ArunkumarSasidharanpillai Sabeena, Santhosh Kuriakose, Binesh Damodaran, Nagaraja Ravishankar, Govindakarnavar Arunkumar
J Gynecol Oncol. 2020;31(2):e20. Published online 2019 October 22 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e20 |
|
| e22 |
Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group StudySurvival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study
Gitte Ørtoft, Claus Høgdall, Estrid S. Hansen, Margit DueholmGitte Ørtoft, Claus Høgdall, Estrid S. Hansen, Margit Dueholm
J Gynecol Oncol. 2020;31(2):e22. Published online 2019 October 4 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e22 |
|
| e23 |
Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancerComparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
Yoo-Na Kim, Yong Jae Lee, Jung-Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae KimYoo-Na Kim, Yong Jae Lee, Jung-Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim
J Gynecol Oncol. 2020;31(2):e23. Published online 2019 October 22 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e23 |
|
| e43 |
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
Ning Zhang, Hanjie Wang, Jili YangNing Zhang, Hanjie Wang, Jili Yang
J Gynecol Oncol. 2020;31(2):e43. Published online 2020 January 2 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e43 |
|
| e44 |
In reply: the evaluation of IgG titers' stability from blood samples is necessaryIn reply: the evaluation of IgG titers' stability from blood samples is necessary
Yung-Taek Ouh, Jae-Kwan LeeYung-Taek Ouh, Jae-Kwan Lee
J Gynecol Oncol. 2020;31(2):e44. Published online 2020 January 28 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e44 |
|
| e50 |
Stage II endometrial cancer requires stratification according to uterine risk factor and sentinel lymph node samplingStage II endometrial cancer requires stratification according to uterine risk factor and sentinel lymph node sampling
Yung-Taek Ouh, Kyung-Jin MinYung-Taek Ouh, Kyung-Jin Min
J Gynecol Oncol. 2020;31(2):e50. Published online 2020 January 17 DOI: http://dx.doi.org/10.3802/jgo.2020.31.e50 |
|
